Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $849,080 - $994,800
4,000 New
4,000 $851,000
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $3.5 Million - $3.89 Million
-15,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $1.11 Million - $1.29 Million
5,000 Added 50.0%
15,000 $3.73 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $1.89 Million - $2.43 Million
10,000 New
10,000 $2.41 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.